These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Synergistic action of silver sulfadiazine and sodium piperacillin on resistant Pseudomonas aeruginosa in vitro and in experimental burn wound infections. Modak S, Fox CL. J Trauma; 1985 Jan; 25(1):27-31. PubMed ID: 3917512 [Abstract] [Full Text] [Related]
3. Comparison between Alpha and silver sulfadiazine ointments in treatment of Pseudomonas infections in 3rd degree burns. Hosseini SV, Tanideh N, Kohanteb J, Ghodrati Z, Mehrabani D, Yarmohammadi H. Int J Surg; 2007 Feb; 5(1):23-6. PubMed ID: 17386910 [Abstract] [Full Text] [Related]
4. Control of experimental burn wound infections: comparative delivery of the antimicrobial agent (silver sulfadiazine) either from a cream base or from a solid synthetic dressing. Robb EC, Nathan P. J Trauma; 1981 Oct; 21(10):889-93. PubMed ID: 7277534 [Abstract] [Full Text] [Related]
5. Sulfadiazine silver-resistant Pseudomonas in Burns. New topical agents. Modak SM, Fox CL. Arch Surg; 1981 Jul; 116(7):854-7. PubMed ID: 6455105 [Abstract] [Full Text] [Related]
8. [Microbiological analysis of experimental burn wounds in swine during treatment with silver sulfadiazine]. Denys A, Grzybowski A, Białek J, Horoszewicz-Małafiej A, Korczak E, Kowalska M, Małafiej E, Szydłowska T. Med Dosw Mikrobiol; 1983 Jul; 35(2):155-62. PubMed ID: 6423917 [No Abstract] [Full Text] [Related]
9. In vivo and in vitro antimicrobial activity of silver sulfadiazine and cerium nitrate. Saffer LD, Rodeheaver GT, Hiebert JM, Edlich RF. Surg Gynecol Obstet; 1980 Aug; 151(2):232-6. PubMed ID: 6773164 [Abstract] [Full Text] [Related]
11. [The effect of different topical agents on pseudomonas infection of burn wound]. Guo Z, Gao W, He L. Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1995 Nov; 11(6):421-4. PubMed ID: 8728928 [Abstract] [Full Text] [Related]
12. Combined topical use of silver sulfadiazine and antibiotics as a possible solution to bacterial resistance in burn wounds. Modak SM, Sampath L, Fox CL. J Burn Care Rehabil; 1988 Nov; 9(4):359-63. PubMed ID: 3146573 [Abstract] [Full Text] [Related]
14. Burn wound sepsis: effect of delayed treatment with topical chemotherapy on survival. Salisbury RE, Bevin AG, Steinkraus GE, Enterline DS. J Trauma; 1980 Feb; 20(2):120-2. PubMed ID: 7354493 [Abstract] [Full Text] [Related]
15. Efficiency of controlled topical delivery of silver sulfadiazine in infected burn wounds. Shanmugasundaram N, Uma TS, Ramyaa Lakshmi TS, Babu M. J Biomed Mater Res A; 2009 May; 89(2):472-82. PubMed ID: 18431769 [Abstract] [Full Text] [Related]
16. Topical therapy and the development of silver sulfadiazine. Fox CL. Surg Gynecol Obstet; 1983 Jul; 157(1):82-8. PubMed ID: 6857475 [Abstract] [Full Text] [Related]
17. Zinc sulfadiazine for topical therapy of pseudomonas infection in burns. Fox CL, Modak SM, Stanford JW. Surg Gynecol Obstet; 1976 Apr; 142(4):553-9. PubMed ID: 816019 [Abstract] [Full Text] [Related]
18. Comparative evaluation of zinc sulfadiazine and silver sulfadiazine in burn wound infection. Fox CL, Rao TN, Azmeth R, Gandhi SS, Modak S. J Burn Care Rehabil; 1990 Apr; 11(2):112-7. PubMed ID: 2335547 [Abstract] [Full Text] [Related]